TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
-3.24%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$709M
AUM Growth
+$709M
(+4.3%)
Cap. Flow
-$3.05M
Cap. Flow
% of AUM
-0.43%
Top 10 Holdings %
Top 10 Hldgs %
39.27%
Holding
116
New
17
Increased
22
Reduced
17
Closed
10
Top Buys
| 1 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
$22.4M |
| 2 |
Intellia Therapeutics
NTLA
|
$12.6M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$10.3M |
| 4 |
KalVista Pharmaceuticals
KALV
|
$7.6M |
| 5 |
Tarsus Pharmaceuticals
TARS
|
$6.42M |
Top Sells
| 1 |
Dianthus Therapeutics
DNTH
|
$74.8M |
| 2 |
BLUE
bluebird bio
BLUE
|
$9.42M |
| 3 |
Capital One
COF
|
$8.75M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$4.6M |
| 5 |
Pyxis Oncology
PYXS
|
$4.58M |
Sector Composition
| 1 | Healthcare | 94.04% |
| 2 | Financials | 5.11% |
| 3 | Real Estate | 0.78% |
| 4 | Consumer Discretionary | 0.07% |
| 5 | Utilities | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Tarsus Pharmaceuticals
TARS
$2.47B
| $38M | 5.37% | 2,140,586 +361,428 | +20% | +$6.42M |
|
2
Mirum Pharmaceuticals
MIRM
$3.71B
| $35.9M | 5.07% | 1,137,107 | – | – |
|
3
AnaptysBio
ANAB
$569M
| $35M | 4.94% | 1,950,609 | – | – |
|
|
4
KalVista Pharmaceuticals
KALV
$678M
| $33.1M | 4.67% | 3,440,345 +788,952 | +30% | +$7.6M |
|
5
Evolus
EOLS
$494M
| $28.3M | 3.99% | 3,097,399 | – | – |
|
|
IMGN
6
DELISTED
Immunogen Inc
IMGN
| $23.8M | 3.36% | 1,500,000 +200,000 | +15% | +$3.17M |
|
|
EQRX
7
DELISTED
EQRx, Inc. Common Stock
EQRX
| $22.4M | 3.16% | +10,086,110 | New | +$22.4M |
|
8
Axsome Therapeutics
AXSM
$6.05B
| $22.4M | 3.16% | 320,000 | – | – |
|
9
Immunocore
IMCR
$1.62B
| $21.1M | 2.97% | 405,600 | – | – |
|
|
FLG
10
Flagstar Financial, Inc.
FLG
$5.33B
| $18.2M | 2.57% | 1,606,600 | – | – |
|
11
Eli Lilly
LLY
$657B
| $16.1M | 2.27% | 30,000 | – | – |
|
|
ITCI
12
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $15.6M | 2.21% | 300,000 | – | – |
|
13
Vaxcyte
PCVX
$4B
| $15.3M | 2.16% | 300,000 | – | – |
|
|
ONC
14
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $15.3M | 2.16% | 85,000 | – | – |
|
|
BLUE
15
DELISTED
bluebird bio
BLUE
| $13M | 1.84% | 4,282,827 -3,100,000 | -42% | -$9.42M |
|
|
16
BioCryst Pharmaceuticals
BCRX
$1.74B
| $12.7M | 1.8% | 1,800,000 -650,000 | -27% | -$4.6M |
|
|
17
Intellia Therapeutics
NTLA
$1.22B
| $12.6M | 1.77% | +397,600 | New | +$12.6M |
|
18
AstraZeneca
AZN
$248B
| $11.5M | 1.62% | 170,000 | – | – |
|
|
THRD
19
DELISTED
Third Harmonic Bio
THRD
| $11.5M | 1.62% | 1,800,000 | – | – |
|
20
Atea Pharmaceuticals
AVIR
$267M
| $10.8M | 1.52% | 3,600,000 +573,545 | +19% | +$1.72M |
|
21
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $10.4M | 1.47% | 600,000 | – | – |
|
|
AVDL
22
Avadel Pharmaceuticals
AVDL
$1.43B
| $10.3M | 1.45% | +1,000,000 | New | +$10.3M |
|
23
Viridian Therapeutics
VRDN
$1.5B
| $10.3M | 1.45% | 669,125 -23,800 | -3% | -$365K |
|
24
Ionis Pharmaceuticals
IONS
$6.79B
| $9.07M | 1.28% | 200,000 | – | – |
|
25
Harmony Biosciences
HRMY
$2.12B
| $8.89M | 1.25% | 271,200 | – | – |
|